AR009849A1 - Compuestos estilbenicos de grupo adamantil, composiciones que los contienen y utilizaciones - Google Patents
Compuestos estilbenicos de grupo adamantil, composiciones que los contienen y utilizacionesInfo
- Publication number
- AR009849A1 AR009849A1 ARP970106240A ARP970106240A AR009849A1 AR 009849 A1 AR009849 A1 AR 009849A1 AR P970106240 A ARP970106240 A AR P970106240A AR P970106240 A ARP970106240 A AR P970106240A AR 009849 A1 AR009849 A1 AR 009849A1
- Authority
- AR
- Argentina
- Prior art keywords
- compounds
- stylbenic
- adamantil
- grupo
- utilizations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/30—Compounds having groups
- C07C43/313—Compounds having groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/30—Compounds having groups
- C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
- C07C65/28—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
- Cosmetics (AREA)
Abstract
Se refiere a nuevos compuestos estilbénicos que presentan como formula general (I) así como la utilizacion de esos ultimos en composicionesfarmacéuticas destinadas a un uso en medicina humana o veterinaria (afecciones dermatologicas,reumatismo , espiratorias, cardiovasculares y oftalmologicasespecialmente), o incluso en composiciones cosméticas. Ar es un radical elegido entre los radicales de formulas (a) a (f).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9616311A FR2757852B1 (fr) | 1996-12-31 | 1996-12-31 | Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
AR009849A1 true AR009849A1 (es) | 2000-05-03 |
Family
ID=9499383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970106240A AR009849A1 (es) | 1996-12-31 | 1997-12-30 | Compuestos estilbenicos de grupo adamantil, composiciones que los contienen y utilizaciones |
Country Status (16)
Country | Link |
---|---|
US (3) | US6214878B1 (es) |
EP (1) | EP0850909B1 (es) |
JP (1) | JP2962699B2 (es) |
AR (1) | AR009849A1 (es) |
AT (1) | ATE199893T1 (es) |
AU (1) | AU699626B2 (es) |
BR (1) | BR9706311A (es) |
CA (1) | CA2224528C (es) |
DE (1) | DE69704335T2 (es) |
DK (1) | DK0850909T3 (es) |
ES (1) | ES2159382T3 (es) |
FR (1) | FR2757852B1 (es) |
GR (1) | GR3035917T3 (es) |
NZ (1) | NZ329462A (es) |
PT (1) | PT850909E (es) |
ZA (1) | ZA9711313B (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2785284B1 (fr) * | 1998-11-02 | 2000-12-01 | Galderma Res & Dev | Analogues de la vitamine d |
FR2801307B1 (fr) * | 1999-11-24 | 2002-12-06 | Galderma Res & Dev | Analogues de la vitamine d |
FR2825087B1 (fr) | 2001-05-22 | 2005-01-14 | Galderma Res & Dev | Analogues de la vitamine d |
SE0102299D0 (sv) * | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
DE10208955A1 (de) * | 2002-02-28 | 2003-09-11 | Bayer Ag | Verfahren zur Herstellung von 2-Halogenalkylnicotinsäuren |
US6864264B1 (en) * | 2002-08-20 | 2005-03-08 | Gloria L. Anderson | 1-adamantyl chalcones for the treatment of proliferative disorders |
CN1301950C (zh) | 2002-08-27 | 2007-02-28 | 盖尔德马研究及发展公司 | 维生素d类似物 |
GB0226930D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
EP1718625A1 (en) * | 2004-02-18 | 2006-11-08 | AstraZeneca AB | Compounds |
EP2048137A1 (en) * | 2004-02-18 | 2009-04-15 | AstraZeneca AB | Benzamide derivatives and their use as glucokinase activating agents. |
TW200600086A (en) * | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
GB0423044D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
AU2005293343B2 (en) | 2004-10-16 | 2009-03-19 | Astrazeneca Ab | Process for making phenoxy benzamide compounds |
GB0423043D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
JP2008542247A (ja) * | 2005-05-24 | 2008-11-27 | アストラゼネカ アクチボラグ | グルコキナーゼモジュレーターとしての2−フェニル置換イミダゾール[4,5b]ピリジン/ピラジンおよびプリン誘導体 |
TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
EP1910350A1 (en) * | 2005-07-09 | 2008-04-16 | AstraZeneca AB | 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
EP2027113A1 (en) * | 2005-07-09 | 2009-02-25 | AstraZeneca AB | Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
EP2305674A1 (en) * | 2005-07-09 | 2011-04-06 | AstraZeneca AB | Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
US9202182B2 (en) * | 2005-08-11 | 2015-12-01 | International Business Machines Corporation | Method and system for analyzing business architecture |
TW200738621A (en) * | 2005-11-28 | 2007-10-16 | Astrazeneca Ab | Chemical process |
US8092720B2 (en) * | 2006-07-25 | 2012-01-10 | National University Corporation Hokkaido University | Polymer-supported metal complex catalyst |
TW200825063A (en) * | 2006-10-23 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
CL2007003061A1 (es) * | 2006-10-26 | 2008-08-01 | Astrazeneca Ab | Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2. |
FR2910320B1 (fr) | 2006-12-21 | 2009-02-13 | Galderma Res & Dev S N C Snc | Emulsion comprenant au moins un retinoide et du peroxyde de benzole |
FR2910321B1 (fr) | 2006-12-21 | 2009-07-10 | Galderma Res & Dev S N C Snc | Gel creme comprenant au moins un retinoide et du peroxyde de benzole |
MX2009006729A (es) * | 2006-12-21 | 2009-08-07 | Astrazeneca Ab | Nuevo compuesto cristalino util como activador de glk. |
FR2931661B1 (fr) | 2008-05-30 | 2010-07-30 | Galderma Res & Dev | Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide. |
BRPI0917589A2 (pt) | 2008-08-04 | 2015-11-17 | Astrazeneca Ab | composto, composição farmacêutica, uso de um composto, método para tratar doenças, processo, combinação farmacêutica, e, reação de metiloxirano-2-carboxilato (ix) com um álcool roh |
GB0902406D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Crystalline polymorphic form |
GB0902434D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Chemical process |
AR076220A1 (es) | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivados de pirazol [4,5 - e] pirimidina |
AR076221A1 (es) * | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad |
WO2016079262A1 (fr) * | 2014-11-20 | 2016-05-26 | Galderma Sa | Compositions comprenant un compose de la famille des avermectines et un compose agoniste d'au moins un des recepteurs de l'acide retinoique pour le traitement de l'acne |
CN107250115B (zh) | 2014-12-19 | 2021-11-05 | 盖尔德马研究及发展公司 | 化合物、其合成方法及其在医药和化妆品中的用途 |
JP2022550432A (ja) | 2019-10-02 | 2022-12-01 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 大動脈弁の石灰化を後退、予防、又は遅延させるためのレチノイン酸受容体(rar)アゴニストの使用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LU86022A1 (fr) | 1985-07-25 | 1987-02-04 | Cird | Derives aromatiques polycyliques,leur procede de preparation et leur application dans les domaines pharmaceutique et cosmetique |
DE3926148A1 (de) * | 1989-08-08 | 1991-02-28 | Basf Ag | Diarylacetylene, ihre herstellung und verwendung |
FR2676052B1 (fr) | 1991-05-02 | 1994-04-29 | Cird Galderma | Nouveaux composes polycycliques aromatiques et leur utilisation en medecine humaine ou veterinaire et en cosmetique. |
US5436369A (en) | 1993-06-16 | 1995-07-25 | Bristol-Myers Squibb Company | Alicyclic phospholipase A2 inhibitors |
FR2719044B1 (fr) * | 1994-04-26 | 1996-05-31 | Cird Galderma | Nouveaux composés bi-aromatiques acétylénés à groupement adamantyle, compositions pharmaceutiques et cosmétiques les contenant et utilisations. |
FR2739557B1 (fr) | 1995-10-09 | 1997-11-14 | Cird Galderma | Utilisation d'un ligand agoniste specifique rar-gamma |
FR2741876B1 (fr) | 1995-12-01 | 1998-01-09 | Cird Galderma | Composes biaromatiques portant un groupement adamantyl en para, compositions pharmaceutiques et cosmetiques les contenant et utilisations |
FR2741878B1 (fr) * | 1995-12-01 | 1998-01-09 | Cird Galderma | Composes biaromatiques portant un groupement adamantyl en ortho, compositions pharmaceutiques et cosmetiques les contenant et utilisations |
US5547893A (en) | 1995-12-27 | 1996-08-20 | Vanguard International Semiconductor Corp. | method for fabricating an embedded vertical bipolar transistor and a memory cell |
PT920312E (pt) | 1996-07-08 | 2005-04-29 | Galderma Res & Dev | Derivados de adamantilo indutores de apoptose e sua utilizacao como agentes anticancerigenos |
-
1996
- 1996-12-31 FR FR9616311A patent/FR2757852B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-15 DK DK97403043T patent/DK0850909T3/da active
- 1997-12-15 EP EP97403043A patent/EP0850909B1/fr not_active Expired - Lifetime
- 1997-12-15 DE DE69704335T patent/DE69704335T2/de not_active Expired - Fee Related
- 1997-12-15 PT PT97403043T patent/PT850909E/pt unknown
- 1997-12-15 ES ES97403043T patent/ES2159382T3/es not_active Expired - Lifetime
- 1997-12-15 AT AT97403043T patent/ATE199893T1/de not_active IP Right Cessation
- 1997-12-17 ZA ZA9111313A patent/ZA9711313B/xx unknown
- 1997-12-18 AU AU48477/97A patent/AU699626B2/en not_active Ceased
- 1997-12-22 BR BR9706311A patent/BR9706311A/pt not_active Application Discontinuation
- 1997-12-22 NZ NZ329462A patent/NZ329462A/xx unknown
- 1997-12-30 CA CA002224528A patent/CA2224528C/fr not_active Expired - Fee Related
- 1997-12-30 AR ARP970106240A patent/AR009849A1/es active IP Right Grant
- 1997-12-31 US US09/002,040 patent/US6214878B1/en not_active Expired - Fee Related
-
1998
- 1998-01-05 JP JP10000501A patent/JP2962699B2/ja not_active Expired - Fee Related
-
2001
- 2001-02-21 US US09/788,469 patent/US20020010337A1/en not_active Abandoned
- 2001-05-22 GR GR20010400771T patent/GR3035917T3/el not_active IP Right Cessation
-
2003
- 2003-10-02 US US10/676,089 patent/US6992095B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69704335D1 (de) | 2001-04-26 |
BR9706311A (pt) | 1999-05-18 |
MX9710466A (es) | 1998-09-30 |
AU4847797A (en) | 1998-07-02 |
EP0850909B1 (fr) | 2001-03-21 |
GR3035917T3 (en) | 2001-08-31 |
ES2159382T3 (es) | 2001-10-01 |
US20040067971A1 (en) | 2004-04-08 |
AU699626B2 (en) | 1998-12-10 |
US20020010337A1 (en) | 2002-01-24 |
CA2224528A1 (fr) | 1998-06-30 |
PT850909E (pt) | 2001-07-31 |
FR2757852A1 (fr) | 1998-07-03 |
US6214878B1 (en) | 2001-04-10 |
CA2224528C (fr) | 2006-07-18 |
ATE199893T1 (de) | 2001-04-15 |
ZA9711313B (en) | 1998-06-23 |
EP0850909A1 (fr) | 1998-07-01 |
US6992095B2 (en) | 2006-01-31 |
FR2757852B1 (fr) | 1999-02-19 |
DE69704335T2 (de) | 2001-07-05 |
DK0850909T3 (da) | 2001-05-21 |
JP2962699B2 (ja) | 1999-10-12 |
NZ329462A (en) | 1999-06-29 |
JPH10226667A (ja) | 1998-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR009849A1 (es) | Compuestos estilbenicos de grupo adamantil, composiciones que los contienen y utilizaciones | |
ES2185711T3 (es) | 1,4-benzotiazepina-1,1-dioxidoshipolipimemicos. | |
ECSP055609A (es) | "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor" | |
ES2142034T3 (es) | Compuestos biaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
ES2122043T3 (es) | Nuevos derivados sustituidos del pirazol, procedimientos para su preparacion y su empleo como herbicidas. | |
ES2175741T3 (es) | Nuevos derivados del acido sulfinico, su procedimiento de preparacion y su utilizacion. | |
MX9301929A (es) | Derivados de pirimidina y procedimientos para su preparacion. | |
ES2119984T3 (es) | Nuevos compuestos propinil bi-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
ES2186015T3 (es) | Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol. | |
ES2100151T3 (es) | Nuevos derivados de benzopirano, procedimientos para su preparacion y su uso y composiciones que contienen los compuestos. | |
MX9207382A (es) | Nuevos compuestos que tienen actividad terapeutica intermediarios para su preparacion, proceso para obtencion de tales compuestos y formulacion farmaceutica que los contiene. | |
AR004700A1 (es) | 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento | |
ES2182161T3 (es) | Utilizacion de derivados de pirimidina para la preparacion de un medicamento para la prevencion del cancer. | |
ES2158597T3 (es) | Compuestos bioaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
ES2163735T3 (es) | Compuestos biarilos heterociclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
MX9307974A (es) | Nuevos derivados de acido hidroxiiminoalquilindolcarboxilico, su obtencion y uso. | |
ES2183180T3 (es) | Nuevos derivados de guanidina, procedimientos para su preparacion y su uso como medicamento. | |
AR002268A1 (es) | Antagonistas de vasopresina de benzacepina triciclicos, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso dedichos compuestos para preparar composiciones farmaceuticas. | |
DK0832081T3 (da) | Bicykliske-aromatiske forbindelser | |
AR005860A1 (es) | Compuestos heterociclicos aromaticos, composiciones farmaceuticas y cosmeticas que los contienen, y su utilización. | |
MX9501849A (es) | Nuevos compuestos biciclicos-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y sus usos. | |
BR9902808A (pt) | Compostos, composição farmacêutica, composição cosmética e uso de uma composição cosmética | |
SE8701406L (sv) | Aromatiska foreningar, deras framtellningsforfarande och deras anvendning inom human- och veterinermedicinen och inom kosmetiken | |
ES2103116T3 (es) | Nuevos compuestos bi-aromaticos derivados de amida, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
AR001354A1 (es) | Compuestos bi-aromaticos derivados de amida, composiciones farmacéuticas y cosméticas que los contien, y utilización de dichos compuestos y composición cosmética. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |